| # | Drug | Count |
|---|---|---|
| 0 | ETOPOSIDE | 7 |
| 1 | METOCLOPRAMIDE | 7 |
| 2 | METOCLOPRAMIDE HYDROCHLORIDE | 7 |
| 3 | ONDANSETRON | 7 |
| 4 | ONDANSETRON HYDROCHLORIDE | 7 |
| 5 | ONDANSETRON TABLETS | 7 |
| 6 | ACETAMINOPHEN | 5 |
| 7 | ACETAMINOPHEN 500MG | 5 |
| 8 | ACETAMINOPHEN TABLET EXTENDED RELEASE | 5 |
| 9 | AMLODIPINE | 5 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ETOPOSIDE PHOSPHATE | 2 | 0.0012 |
| 1 | GLYCOPYRROLATE | 5 | 0.0009 |
| 2 | MESNA INJECTION | 5 | 0.0006 |
| 3 | MESNA | 5 | 0.0006 |
| 4 | DOLUTEGRAVIR SODIUM AND LAMIVUDINE | 2 | 0.0006 |
| 5 | IFOSFAMIDE FOR INJECTION | 5 | 0.0002 |
| 6 | BLEOMYCIN SULFATE | 2 | 0.0002 |
| 7 | PROCHLORPERAZINE | 4 | 0.0001 |
| 8 | FILGRASTIM | 5 | 0.0001 |
| 9 | ETOPOSIDE | 7 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Phenothiazine [EPC] | 4 | 0.0001 |
| 1 | Topoisomerase Inhibitor [EPC] | 7 | 0.0001 |
| 2 | Serotonin-3 Receptor Antagonist [EPC] | 7 | 0.0001 |
| 3 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 2 | 0.0000 |
| 4 | Histamine-2 Receptor Antagonist [EPC] | 5 | 0.0000 |
| 5 | Leukocyte Growth Factor [EPC] | 5 | 0.0000 |
| 6 | Azole Antifungal [EPC] | 5 | 0.0000 |
| 7 | Platinum-based Drug [EPC] | 7 | 0.0000 |
| 8 | Alkylating Drug [EPC] | 6 | 0.0000 |
| 9 | Integrin Receptor Antagonist [EPC] | 2 | 0.0000 |